CR1 and COVID-19: In the first place, the expression patterns of CR1 and TAP2 exhibited significant variations across different severities of COVID-19, indicating that measuring their expression levels on the ocular surface, such as in tears, may serve as a potential predictor of COVID-19 prognosis in clinical settings.